Insulin Analog [EPC]

Insulin Analog [EPC] was reported 449301 times

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 APPENDICOLITH 284 0.7339
1 HYPOGLYCAEMIA UNAWARENESS 239 0.6676
2 HYPOGLYCAEMIC UNCONSCIOUSNESS 1198 0.6044
3 DEVICE OPERATIONAL ISSUE 2127 0.4940
4 HYPOGLYCAEMIC SEIZURE 435 0.4791
5 DIABETIC RETINOPATHY 1618 0.4759
6 SHOCK HYPOGLYCAEMIC 217 0.4559
7 BLOOD GLUCOSE FLUCTUATION 4718 0.4301
8 BLOOD GLUCOSE INCREASED 77778 0.4124
9 BLOOD GLUCOSE DECREASED 19425 0.4041
10 PULMONARY VASCULITIS 214 0.3978
11 INSULIN RESISTANCE 826 0.3965
12 BLOOD GLUCOSE ABNORMAL 6734 0.3642
13 DIABETES MELLITUS INADEQUATE CONTROL 6311 0.3561
14 HYPOGLYCAEMIC COMA 1021 0.3539
15 PRODUCT STORAGE ISSUE 1327 0.3499
16 GLYCOSYLATED HAEMOGLOBIN INCREASED 7999 0.3166
17 DIABETIC METABOLIC DECOMPENSATION 438 0.3153
18 HYPOGLYCAEMIA 13384 0.2757
19 DIABETIC NEUROPATHY 1290 0.2603
20 ACCIDENTAL UNDERDOSE 3631 0.2520
21 PRODUCT DISPENSING ISSUE 1078 0.2518
22 BLOOD KETONE BODY INCREASED 194 0.2484
23 DIABETIC KETOACIDOSIS 5778 0.2403
24 CAROTID ARTERY THROMBOSIS 203 0.2391
25 INTERCEPTED DRUG DISPENSING ERROR 345 0.2319
26 DIABETIC COMA 631 0.2251
27 INTERCEPTED PRODUCT SELECTION ERROR 286 0.2197
28 HYPERGLYCAEMIA 7659 0.2100
29 DIABETIC COMPLICATION 535 0.2099
30 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 251 0.2095
31 DIABETIC FOOT 638 0.2082
32 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 221 0.2081
33 WRONG DRUG ADMINISTERED 1774 0.1989
34 NEPHROGENIC ANAEMIA 888 0.1915
35 GLYCOSYLATED HAEMOGLOBIN DECREASED 308 0.1912
36 KETOACIDOSIS 1392 0.1858
37 HYPERPARATHYROIDISM SECONDARY 453 0.1806
38 KETOSIS 194 0.1788
39 RETINOPATHY 658 0.1762
40 DIABETIC NEPHROPATHY 361 0.1639
41 INCORRECT PRODUCT STORAGE 2035 0.1547
42 WRONG PATIENT RECEIVED PRODUCT 453 0.1547
43 HYPOGLYCAEMIA NEONATAL 244 0.1507
44 ADJUSTMENT DISORDER 193 0.1485
45 NEURITIS 223 0.1443
46 URINE KETONE BODY PRESENT 221 0.1400
47 FOOT AMPUTATION 192 0.1319
48 LEG AMPUTATION 536 0.1299
49 IMPAIRED GASTRIC EMPTYING 1752 0.1284
50 GASTROINTESTINAL HYPOMOTILITY 287 0.1272
51 GANGRENE 764 0.1267
52 PRODUCT STORAGE ERROR 11025 0.1258
53 INJURY ASSOCIATED WITH DEVICE 2495 0.1224
54 EYE HAEMORRHAGE 1624 0.1216
55 TOE AMPUTATION 605 0.1190
56 VISUAL IMPAIRMENT 14387 0.1160
57 DRUG DISPENSING ERROR 1755 0.1147
58 HYPERPHOSPHATAEMIA 242 0.1125
59 RENAL TRANSPLANT 403 0.1114
60 EUGLYCAEMIC DIABETIC KETOACIDOSIS 454 0.1098
61 PANCREATIC CARCINOMA METASTATIC 304 0.1068
62 END STAGE RENAL DISEASE 1941 0.1063
63 BLOOD PHOSPHORUS INCREASED 275 0.1006
64 PANCREATIC DISORDER 492 0.0998
65 CATARACT OPERATION 585 0.0985
66 RESPIRATORY SYMPTOM 276 0.0969
67 REBOUND ACID HYPERSECRETION 290 0.0958
68 MACULAR DEGENERATION 1137 0.0951
69 WRONG PRODUCT ADMINISTERED 641 0.0948
70 RETINAL DISORDER 246 0.0945
71 VISUAL ACUITY REDUCED 3139 0.0944
72 DEVICE MECHANICAL ISSUE 1293 0.0942
73 CATARACT 5547 0.0931
74 TYPE 1 DIABETES MELLITUS 551 0.0914
75 MULTIPLE USE OF SINGLE-USE PRODUCT 509 0.0906
76 PRODUCT DISPENSING ERROR 1954 0.0896
77 INJECTION SITE SCAR 253 0.0887
78 ARTERIAL OCCLUSIVE DISEASE 678 0.0862
79 BLINDNESS UNILATERAL 1212 0.0858
80 VASCULAR GRAFT 243 0.0843
81 RENAL FAILURE CHRONIC 647 0.0841
82 PANCREATITIS CHRONIC 197 0.0831
83 HYPOACUSIS 3578 0.0830
84 BLINDNESS 3380 0.0829
85 VITREOUS HAEMORRHAGE 219 0.0792
86 PERSONALITY DISORDER 207 0.0789
87 INJECTION SITE INJURY 437 0.0787
88 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 428 0.0786
89 NORMOCHROMIC NORMOCYTIC ANAEMIA 230 0.0765
90 EYE OPERATION 352 0.0763
91 ISCHAEMIC CARDIOMYOPATHY 232 0.0756
92 POOR QUALITY DRUG ADMINISTERED 476 0.0735
93 RETINAL HAEMORRHAGE 510 0.0715
94 PERIPHERAL VASCULAR DISORDER 355 0.0688
95 AORTIC STENOSIS 239 0.0686
96 RETINAL DETACHMENT 629 0.0684
97 CARDIAC OPERATION 582 0.0676
98 UNDERDOSE 4909 0.0672
99 HYPERKALAEMIA 2294 0.0653
100 GLAUCOMA 1257 0.0652
101 INCORRECT DOSE ADMINISTERED 14874 0.0651
102 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 266 0.0651
103 HEARING IMPAIRED 389 0.0648
104 CORONARY ARTERY BYPASS 367 0.0638
105 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11408 0.0632
106 CORONARY ARTERY OCCLUSION 865 0.0630
107 CAROTID ARTERY OCCLUSION 230 0.0630
108 LEFT VENTRICULAR HYPERTROPHY 269 0.0628
109 DIALYSIS 868 0.0611
110 EYE DISORDER 2011 0.0611
111 ARTERIOSCLEROSIS 562 0.0597
112 INTENTIONAL DEVICE MISUSE 263 0.0596
113 CHRONIC KIDNEY DISEASE 4509 0.0593
114 INFUSION SITE HAEMORRHAGE 195 0.0592
115 EXPIRED PRODUCT ADMINISTERED 1970 0.0592
116 POOR PERIPHERAL CIRCULATION 250 0.0586
117 DRUG ADMINISTRATION ERROR 1786 0.0581
118 HEMIPLEGIA 484 0.0581
119 NEPHROPATHY 538 0.0576
120 BLOOD URIC ACID INCREASED 330 0.0571
121 LACTIC ACIDOSIS 1838 0.0567
122 RENAL FAILURE 7527 0.0566
123 INCORRECT DOSE ADMINISTERED BY DEVICE 1474 0.0562
124 ARTERIOSCLEROSIS CORONARY ARTERY 372 0.0561
125 BLOOD POTASSIUM INCREASED 911 0.0561
126 HUNGER 780 0.0559
127 LOCALISED INFECTION 1341 0.0554
128 HAEMORRHAGIC ANAEMIA 242 0.0550
129 CORONARY ARTERY DISEASE 1664 0.0549
130 HYPOVOLAEMIA 319 0.0545
131 TRIGGER FINGER 221 0.0540
132 ABSCESS LIMB 230 0.0539
133 LIQUID PRODUCT PHYSICAL ISSUE 392 0.0537
134 DIABETES MELLITUS 4091 0.0536
135 FRUSTRATION 192 0.0535
136 SENSORY LOSS 431 0.0535
137 HYPERLIPIDAEMIA 639 0.0534
138 DEMENTIA 1491 0.0533
139 WHEELCHAIR USER 235 0.0528
140 OVERWEIGHT 283 0.0526
141 RENAL DISORDER 2441 0.0523
142 CYSTIC FIBROSIS 288 0.0520
143 CARDIAC FAILURE CONGESTIVE 4178 0.0520
144 RENAL TUBULAR NECROSIS 510 0.0519
145 STENT PLACEMENT 419 0.0519
146 EXPIRED DRUG ADMINISTERED 257 0.0519
147 ANGIOPATHY 291 0.0519
148 DEVICE MALFUNCTION 3640 0.0517
149 CARDIOGENIC SHOCK 743 0.0517
150 DEVICE FAILURE 786 0.0516
151 PRE-ECLAMPSIA 244 0.0513
152 INJECTION SITE EXTRAVASATION 630 0.0510
153 VENTRICULAR FIBRILLATION 566 0.0509
154 MACULAR OEDEMA 283 0.0504
155 ANGINA UNSTABLE 328 0.0504
156 DISABILITY 995 0.0503
157 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2341 0.0501
158 ACUTE KIDNEY INJURY 7653 0.0500
159 THIRST 893 0.0499
160 IRON DEFICIENCY 224 0.0498
161 INJECTION SITE NODULE 548 0.0497
162 DEVICE ISSUE 4451 0.0496
163 INJECTION SITE HAEMORRHAGE 3929 0.0491
164 OSTEOMYELITIS 870 0.0480
165 RALES 279 0.0480
166 MALNUTRITION 537 0.0480
167 RENAL FAILURE ACUTE 2020 0.0476
168 RENAL INJURY 1410 0.0474
169 CEREBROVASCULAR ACCIDENT 7949 0.0469
170 DEVICE DEFECTIVE 811 0.0467
171 EXPOSURE VIA SKIN CONTACT 1211 0.0467
172 SKIN ULCER 1200 0.0464
173 APPENDICITIS 428 0.0458
174 PULMONARY ALVEOLAR HAEMORRHAGE 257 0.0458
175 SPINAL COLUMN STENOSIS 216 0.0457
176 PRODUCT DOSE OMISSION 2967 0.0454
177 CARPAL TUNNEL SYNDROME 635 0.0453
178 BLOOD UREA INCREASED 759 0.0453
179 PHARMACEUTICAL PRODUCT COMPLAINT 1172 0.0451
180 HEPATIC CIRRHOSIS 844 0.0449
181 POLYURIA 367 0.0448
182 LIMB INJURY 1214 0.0446
183 ACIDOSIS 338 0.0442
184 NEUROLOGICAL SYMPTOM 252 0.0440
185 OBSTRUCTIVE AIRWAYS DISORDER 489 0.0439
186 DECUBITUS ULCER 358 0.0439
187 MYASTHENIA GRAVIS 353 0.0437
188 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 221 0.0436
189 ANGINA PECTORIS 1247 0.0435
190 DRUG DOSE OMISSION 7181 0.0434
191 KIDNEY TRANSPLANT REJECTION 208 0.0433
192 GENERALISED OEDEMA 533 0.0430
193 GLOMERULAR FILTRATION RATE DECREASED 529 0.0430
194 UROSEPSIS 397 0.0430
195 BENIGN PROSTATIC HYPERPLASIA 222 0.0429
196 ANKLE FRACTURE 662 0.0427
197 GOUT 767 0.0427
198 CARDIAC PACEMAKER INSERTION 254 0.0426
199 THYROID DISORDER 656 0.0425
200 HEPATIC ENCEPHALOPATHY 396 0.0424
201 GESTATIONAL DIABETES 202 0.0423
202 CORONARY ARTERY STENOSIS 213 0.0423
203 HYPOPHOSPHATAEMIA 310 0.0419
204 TROPONIN INCREASED 319 0.0419
205 PANCREATITIS ACUTE 939 0.0417
206 SLEEP APNOEA SYNDROME 795 0.0416
207 LYMPHOEDEMA 288 0.0416
208 VISUAL DISTURBANCE 238 0.0414
209 AMMONIA INCREASED 210 0.0411
210 HYPERKERATOSIS 227 0.0411
211 PANCREATITIS 2168 0.0410
212 ACUTE MYOCARDIAL INFARCTION 1206 0.0409
213 METABOLIC ACIDOSIS 1307 0.0408
214 MULTI-ORGAN FAILURE 704 0.0407
215 INJECTION SITE MASS 1501 0.0406
216 INFUSION SITE PAIN 521 0.0404
217 ACUTE RESPIRATORY FAILURE 771 0.0400
218 ACUTE CORONARY SYNDROME 331 0.0399
219 FLANK PAIN 372 0.0396
220 BACK DISORDER 644 0.0396
221 NEUROPATHY PERIPHERAL 3752 0.0394
222 ARTHRITIS 3095 0.0393
223 PROTEIN URINE PRESENT 196 0.0393
224 NERVE INJURY 435 0.0391
225 TRANSIENT ISCHAEMIC ATTACK 1318 0.0390
226 ERUCTATION 755 0.0390
227 FOOT FRACTURE 736 0.0388
228 INJECTION SITE BRUISING 3097 0.0388
229 INCORRECT PRODUCT ADMINISTRATION DURATION 839 0.0387
230 WEIGHT DECREASED 10763 0.0385
231 INCOHERENT 249 0.0384
232 HAEMODIALYSIS 321 0.0382
233 CELLULITIS 1925 0.0382
234 NERVE COMPRESSION 352 0.0381
235 FLUID OVERLOAD 555 0.0381
236 ASCITES 1121 0.0381
237 HYPERTRIGLYCERIDAEMIA 223 0.0381
238 APPETITE DISORDER 252 0.0380
239 MYOCARDIAL INFARCTION 6615 0.0379
240 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1976 0.0378
241 UPPER LIMB FRACTURE 754 0.0378
242 CARDIAC VALVE DISEASE 216 0.0377
243 ACUTE PULMONARY OEDEMA 210 0.0374
244 DEHYDRATION 4985 0.0373
245 EATING DISORDER 794 0.0373
246 BLINDNESS TRANSIENT 274 0.0371
247 CARDIAC DISORDER 3474 0.0371
248 FEAR 998 0.0371
249 MYOPATHY 319 0.0369
250 LOSS OF CONSCIOUSNESS 4720 0.0368
251 RENAL IMPAIRMENT 3074 0.0366
252 PYELONEPHRITIS 316 0.0364
253 ATELECTASIS 352 0.0364
254 HYPERHIDROSIS 4693 0.0364
255 LOWER LIMB FRACTURE 699 0.0363
256 PULMONARY OEDEMA 1629 0.0363
257 ELECTROLYTE IMBALANCE 422 0.0363
258 ATRIOVENTRICULAR BLOCK 280 0.0362
259 COLD SWEAT 638 0.0362
260 HEPATIC STEATOSIS 672 0.0360
261 MYOCARDIAL ISCHAEMIA 410 0.0360
262 HEMIPARESIS 610 0.0360
263 INTENTIONAL PRODUCT MISUSE 3148 0.0359
264 DEVICE USE ISSUE 628 0.0359
265 ANURIA 308 0.0358
266 PANCREATIC CARCINOMA 1028 0.0356
267 WALKING AID USER 234 0.0355
268 MITRAL VALVE INCOMPETENCE 401 0.0354
269 FLUID RETENTION 1802 0.0354
270 BLOOD CREATININE INCREASED 2305 0.0353
271 MOTOR DYSFUNCTION 359 0.0352
272 MEMORY IMPAIRMENT 4834 0.0351
273 VASCULITIS 409 0.0351
274 FULL BLOOD COUNT ABNORMAL 370 0.0349
275 ROAD TRAFFIC ACCIDENT 1461 0.0349
276 PEMPHIGOID 263 0.0348
277 BLOOD PRESSURE DIASTOLIC DECREASED 257 0.0348
278 INFARCTION 238 0.0347
279 CARDIOMEGALY 427 0.0347
280 BLOOD MAGNESIUM DECREASED 299 0.0346
281 INJECTION SITE DISCOMFORT 364 0.0346
282 MENTAL STATUS CHANGES 961 0.0346
283 OLIGURIA 214 0.0344
284 BLOOD TRIGLYCERIDES INCREASED 607 0.0343
285 ATRIAL FLUTTER 274 0.0343
286 BLOOD CALCIUM INCREASED 299 0.0341
287 OEDEMA PERIPHERAL 4136 0.0339
288 MEDICATION ERROR 1885 0.0339
289 SOPOR 445 0.0336
290 SEPSIS 3739 0.0335
291 POLLAKIURIA 1395 0.0334
292 HYPOTHERMIA 338 0.0334
293 INJECTION SITE PAIN 10240 0.0333
294 TRICUSPID VALVE INCOMPETENCE 265 0.0333
295 FRUSTRATION TOLERANCE DECREASED 268 0.0331
296 FALL 11022 0.0331
297 CYSTITIS 1053 0.0330
298 HYPOPHAGIA 843 0.0329
299 INTERVERTEBRAL DISC PROTRUSION 719 0.0329
300 BLOOD PRESSURE SYSTOLIC INCREASED 641 0.0328
301 ROTATOR CUFF SYNDROME 422 0.0328
302 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 556 0.0327
303 INJECTION SITE DISCOLOURATION 409 0.0327
304 IRON DEFICIENCY ANAEMIA 302 0.0327
305 COORDINATION ABNORMAL 456 0.0327
306 WOUND 911 0.0326
307 PRODUCT QUALITY ISSUE 4418 0.0325
308 ANOREXIA 419 0.0325
309 CARDIAC MURMUR 281 0.0324
310 STAPHYLOCOCCAL INFECTION 1070 0.0324
311 NERVOUSNESS 1691 0.0323
312 RENAL CYST 257 0.0323
313 SCAR 552 0.0322
314 WEIGHT INCREASED 7213 0.0322
315 CONCUSSION 248 0.0320
316 HEAD INJURY 1013 0.0320
317 JOINT INJURY 683 0.0319
318 HYPOXIA 1123 0.0319
319 BRAIN INJURY 319 0.0318
320 TUBULOINTERSTITIAL NEPHRITIS 596 0.0318
321 VISION BLURRED 4354 0.0317
322 PREMATURE BABY 952 0.0316
323 CARDIAC FAILURE 2535 0.0315
324 POSTOPERATIVE WOUND INFECTION 213 0.0315
325 SKIN HAEMORRHAGE 466 0.0314
326 BLOOD POTASSIUM DECREASED 944 0.0314
327 SINUS CONGESTION 424 0.0314
328 OBESITY 498 0.0312
329 LIMB DISCOMFORT 966 0.0312
330 BLOOD CHOLESTEROL INCREASED 1453 0.0311
331 TREMOR 5164 0.0311
332 BACK INJURY 337 0.0310
333 HYPERCHOLESTEROLAEMIA 299 0.0309
334 UNRESPONSIVE TO STIMULI 799 0.0309
335 HAND FRACTURE 219 0.0309
336 KIDNEY INFECTION 606 0.0309
337 PRESYNCOPE 748 0.0307
338 HYPERTENSIVE CRISIS 340 0.0305
339 URINE OUTPUT DECREASED 267 0.0305
340 ACCIDENT 363 0.0304
341 WOUND INFECTION 332 0.0303
342 HAEMORRHAGE 3164 0.0302
343 RHABDOMYOLYSIS 1251 0.0300
344 COMA 1428 0.0300
345 MULTIPLE ORGAN DYSFUNCTION SYNDROME 848 0.0299
346 WEIGHT FLUCTUATION 313 0.0299
347 CHOLELITHIASIS 981 0.0299
348 ATRIAL SEPTAL DEFECT 250 0.0298
349 CARDIAC FAILURE ACUTE 198 0.0297
350 HIP FRACTURE 955 0.0297
351 CONFUSIONAL STATE 4788 0.0296
352 ATRIAL FIBRILLATION 2884 0.0296
353 INTERNATIONAL NORMALISED RATIO INCREASED 844 0.0296
354 BACTERIAL INFECTION 552 0.0296
355 DRUG PRESCRIBING ERROR 568 0.0295
356 DECREASED APPETITE 6859 0.0295
357 VITREOUS FLOATERS 290 0.0295
358 BODY TEMPERATURE DECREASED 290 0.0294
359 LEFT VENTRICULAR DYSFUNCTION 197 0.0294
360 BLOOD ALBUMIN DECREASED 233 0.0293
361 INCREASED APPETITE 561 0.0293
362 ELECTROCARDIOGRAM ABNORMAL 230 0.0293
363 HYPONATRAEMIA 1650 0.0293
364 POST PROCEDURAL INFECTION 238 0.0292
365 LIPASE INCREASED 224 0.0292
366 BLOOD PRESSURE ABNORMAL 579 0.0291
367 SINUS DISORDER 576 0.0291
368 LOWER GASTROINTESTINAL HAEMORRHAGE 215 0.0291
369 SCIATICA 463 0.0290
370 DYSPNOEA EXERTIONAL 1093 0.0290
371 LARGE INTESTINE POLYP 201 0.0290
372 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 497 0.0290
373 ECONOMIC PROBLEM 437 0.0288
374 HEPATOMEGALY 283 0.0288
375 CHOLECYSTITIS 343 0.0288
376 CAESAREAN SECTION 334 0.0287
377 LEUKOCYTOSIS 519 0.0287
378 CLOSTRIDIUM DIFFICILE COLITIS 304 0.0286
379 GASTROENTERITIS 418 0.0286
380 CEREBRAL INFARCTION 699 0.0286
381 PARALYSIS 409 0.0285
382 INTERVERTEBRAL DISC DEGENERATION 264 0.0285
383 HAEMOPTYSIS 795 0.0285
384 ABDOMINAL DISTENSION 2972 0.0284
385 UPPER GASTROINTESTINAL HAEMORRHAGE 478 0.0284
386 DYSARTHRIA 1069 0.0284
387 PRURITUS GENERALISED 613 0.0283
388 APHASIA 856 0.0283
389 RIB FRACTURE 583 0.0283
390 ASPIRATION 310 0.0283
391 URINARY TRACT INFECTION 4827 0.0283
392 PULMONARY FIBROSIS 540 0.0281
393 ENCEPHALOPATHY 691 0.0281
394 PHARYNGITIS 349 0.0281
395 SPINAL OSTEOARTHRITIS 247 0.0281
396 PERICARDIAL EFFUSION 650 0.0281
397 BLOOD CALCIUM DECREASED 315 0.0280
398 DISORIENTATION 1108 0.0279
399 ORTHOSTATIC HYPOTENSION 486 0.0279
400 PULMONARY MASS 415 0.0278
401 INJECTION SITE INDURATION 361 0.0278
402 GAIT INABILITY 930 0.0278
403 HYPERTENSION 5875 0.0277
404 BLOOD SODIUM DECREASED 522 0.0277
405 MALAISE 12144 0.0277
406 DEAFNESS 723 0.0276
407 OEDEMA 1495 0.0275
408 PULMONARY HYPERTENSION 574 0.0275
409 VENTRICULAR TACHYCARDIA 455 0.0275
410 NEURALGIA 669 0.0275
411 DIVERTICULUM 195 0.0274
412 RESPIRATORY FAILURE 2001 0.0274
413 HYPOKALAEMIA 1260 0.0273
414 MOUTH HAEMORRHAGE 200 0.0273
415 TYPE 2 DIABETES MELLITUS 918 0.0272
416 VISUAL FIELD DEFECT 197 0.0272
417 NODULE 355 0.0272
418 GENERAL PHYSICAL HEALTH DETERIORATION 3123 0.0270
419 FUNGAL INFECTION 899 0.0269
420 PREMATURE DELIVERY 429 0.0269
421 HAEMORRHAGIC STROKE 210 0.0269
422 SEPTIC SHOCK 1170 0.0269
423 ESCHERICHIA INFECTION 221 0.0268
424 SHOCK HAEMORRHAGIC 218 0.0268
425 ABASIA 661 0.0267
426 ANAEMIA 5100 0.0267
427 GASTROINTESTINAL HAEMORRHAGE 2231 0.0267
428 LOW BIRTH WEIGHT BABY 212 0.0267
429 HAEMATOCRIT DECREASED 529 0.0266
430 CARDIOMYOPATHY 394 0.0266
431 HYPOTHYROIDISM 851 0.0266
432 BEDRIDDEN 350 0.0266
433 TACHYPNOEA 362 0.0266
434 DYSSTASIA 774 0.0265
435 POST PROCEDURAL COMPLICATION 509 0.0265
436 CEREBRAL DISORDER 196 0.0265
437 GASTROENTERITIS VIRAL 477 0.0264
438 HYPOMAGNESAEMIA 367 0.0263
439 SHOCK 606 0.0263
440 COVID-19 PNEUMONIA 311 0.0263
441 ASTHENIA 9877 0.0262
442 BRAIN NEOPLASM 241 0.0262
443 ANHEDONIA 687 0.0261
444 LUNG DISORDER 1281 0.0261
445 ISCHAEMIC STROKE 466 0.0261
446 PRODUCT USE ISSUE 4894 0.0260
447 RESPIRATORY TRACT CONGESTION 413 0.0260
448 OSTEOARTHRITIS 1102 0.0260
449 VOMITING 12190 0.0259
450 GASTRITIS 682 0.0259
451 SUPRAVENTRICULAR TACHYCARDIA 248 0.0259
452 ALTERED STATE OF CONSCIOUSNESS 560 0.0258
453 BLOOD PRESSURE INCREASED 3944 0.0258
454 GAIT DISTURBANCE 4937 0.0258
455 CHOLESTASIS 495 0.0258
456 LACERATION 242 0.0257
457 FEELING JITTERY 490 0.0257
458 BACTERAEMIA 305 0.0257
459 FEELING ABNORMAL 6147 0.0256
460 SYNCOPE 2566 0.0256
461 PERIPHERAL SWELLING 3950 0.0256
462 SLUGGISHNESS 261 0.0256
463 ULCER 407 0.0256
464 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5184 0.0256
465 ILEUS 317 0.0255
466 HAEMATOMA 660 0.0254
467 SINUS BRADYCARDIA 246 0.0254
468 CHEST PAIN 4694 0.0253
469 HICCUPS 208 0.0253
470 COLON CANCER 377 0.0253
471 EMPHYSEMA 255 0.0253
472 CARDIO-RESPIRATORY ARREST 1056 0.0252
473 VITAMIN D DEFICIENCY 246 0.0252
474 COAGULOPATHY 420 0.0252
475 POOR QUALITY PRODUCT ADMINISTERED 265 0.0251
476 LUNG INFILTRATION 222 0.0251
477 BRONCHITIS 1859 0.0251
478 PRODUCT ODOUR ABNORMAL 263 0.0251
479 PLEURAL EFFUSION 1528 0.0251
480 RENAL PAIN 266 0.0251
481 CARDIOVASCULAR DISORDER 636 0.0250
482 BLOOD IRON DECREASED 297 0.0250
483 DEPRESSED LEVEL OF CONSCIOUSNESS 990 0.0250
484 SNEEZING 561 0.0250
485 SPEECH DISORDER 1308 0.0249
486 PNEUMONIA 8075 0.0249
487 UNEVALUABLE EVENT 1887 0.0249
488 IMPAIRED HEALING 818 0.0249
489 PSYCHOLOGICAL TRAUMA 215 0.0249
490 EXOSTOSIS 227 0.0248
491 PERITONITIS BACTERIAL 250 0.0248
492 WRIST FRACTURE 297 0.0248
493 FEEDING DISORDER 502 0.0247
494 MUSCULAR WEAKNESS 2809 0.0247
495 MATERNAL EXPOSURE DURING PREGNANCY 2200 0.0247
496 DIZZINESS POSTURAL 239 0.0246
497 PRODUCT PRESCRIBING ERROR 587 0.0246
498 BODY HEIGHT DECREASED 263 0.0246
499 GASTROOESOPHAGEAL REFLUX DISEASE 1979 0.0246
500 PULMONARY CONGESTION 324 0.0246
501 AFFECT LABILITY 236 0.0245
502 HYPOKINESIA 356 0.0245
503 MOBILITY DECREASED 1753 0.0244
504 HAEMATURIA 835 0.0244
505 THROMBOSIS 1957 0.0243
506 URINARY INCONTINENCE 720 0.0243
507 HYPOTENSION 4874 0.0243
508 BRADYCARDIA 1288 0.0243
509 BLOOD ALKALINE PHOSPHATASE INCREASED 603 0.0243
510 CARDIAC ARREST 2003 0.0242
511 PRODUCTIVE COUGH 1148 0.0240
512 INTERNAL HAEMORRHAGE 273 0.0239
513 DRUG INTERACTION 3787 0.0238
514 HIATUS HERNIA 309 0.0238
515 PSEUDOMONAS INFECTION 204 0.0238
516 LEUKAEMIA 224 0.0237
517 MUSCULOSKELETAL DISCOMFORT 408 0.0237
518 HAIR DISORDER 195 0.0236
519 DYSPEPSIA 2326 0.0236
520 CONSTIPATION 5152 0.0236
521 AMNESIA 1534 0.0236
522 DRUG EXPOSURE DURING PREGNANCY 801 0.0235
523 ABSCESS 375 0.0235
524 MELAENA 517 0.0235
525 TOOTHACHE 425 0.0235
526 NAUSEA 18556 0.0234
527 FIBROMYALGIA 569 0.0234
528 MASS 327 0.0234
529 TREATMENT NONCOMPLIANCE 1278 0.0233
530 PROTEINURIA 444 0.0233
531 MUSCLE ATROPHY 295 0.0233
532 LIVER DISORDER 1030 0.0232
533 OFF LABEL USE 20267 0.0231
534 SUBDURAL HAEMATOMA 331 0.0231
535 DYSURIA 851 0.0231
536 HAEMATEMESIS 585 0.0231
537 NOCTURIA 280 0.0230
538 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 203 0.0229
539 ANAL INCONTINENCE 206 0.0229
540 MYOSITIS 205 0.0228
541 RESPIRATORY DISTRESS 630 0.0228
542 NEPHROLITHIASIS 1046 0.0228
543 ARRHYTHMIA 1079 0.0228
544 FLATULENCE 1290 0.0227
545 ACCIDENTAL OVERDOSE 831 0.0227
546 ABDOMINAL PAIN UPPER 4677 0.0227
547 PAIN IN EXTREMITY 6691 0.0227
548 SPINAL DISORDER 215 0.0227
549 WHEEZING 1345 0.0227
550 DIZZINESS 11277 0.0226
551 NEEDLE ISSUE 658 0.0226
552 HEPATIC FAILURE 681 0.0226
553 CONTUSION 2173 0.0225
554 SPINAL FRACTURE 452 0.0225
555 INABILITY TO AFFORD MEDICATION 224 0.0225
556 GALLBLADDER DISORDER 402 0.0225
557 SPLENOMEGALY 263 0.0224
558 RETCHING 478 0.0224
559 PNEUMONIA ASPIRATION 560 0.0224
560 RESPIRATORY RATE INCREASED 199 0.0224
561 HOSPITALISATION 3443 0.0224
562 BALANCE DISORDER 1936 0.0224
563 SUBARACHNOID HAEMORRHAGE 228 0.0224
564 INCONTINENCE 236 0.0223
565 SEASONAL ALLERGY 316 0.0223
566 SUDDEN DEATH 236 0.0223
567 INJECTION SITE HAEMATOMA 323 0.0222
568 DISCOMFORT 1358 0.0222
569 LIGAMENT SPRAIN 220 0.0222
570 INFLUENZA 2473 0.0222
571 BLOOD PRESSURE DECREASED 1473 0.0221
572 ACCIDENTAL EXPOSURE TO PRODUCT 2283 0.0221
573 DYSPNOEA 12511 0.0221
574 DEVICE LEAKAGE 954 0.0220
575 SCRATCH 232 0.0220
576 EXPOSURE DURING PREGNANCY 1366 0.0220
577 BLADDER DISORDER 218 0.0219
578 ABDOMINAL PAIN 5101 0.0219
579 INCORRECT DRUG ADMINISTRATION DURATION 614 0.0218
580 NEOPLASM MALIGNANT 1457 0.0218
581 HAEMOGLOBIN DECREASED 2240 0.0218
582 TENDERNESS 227 0.0218
583 HEART RATE IRREGULAR 492 0.0218
584 LUNG INFECTION 338 0.0217
585 KNEE OPERATION 214 0.0217
586 EYE INFECTION 245 0.0217
587 HYPERSOMNIA 622 0.0217
588 TOXIC EPIDERMAL NECROLYSIS 328 0.0216
589 LETHARGY 1240 0.0215
590 MUSCLE SPASTICITY 264 0.0215
591 NEUTROPHIL COUNT INCREASED 220 0.0215
592 JAUNDICE 577 0.0214
593 COELIAC DISEASE 210 0.0214
594 SWELLING 2001 0.0214
595 JOINT DISLOCATION 226 0.0214
596 HYPOCALCAEMIA 404 0.0213
597 INJURY 1493 0.0212
598 PALLOR 577 0.0212
599 HYPERCALCAEMIA 261 0.0211
600 FEELING COLD 588 0.0211
601 ILLNESS 2171 0.0211
602 CEREBRAL HAEMORRHAGE 754 0.0210
603 HAIR COLOUR CHANGES 262 0.0210
604 MENTAL IMPAIRMENT 510 0.0210
605 UPPER RESPIRATORY TRACT INFECTION 972 0.0210
606 SKIN LACERATION 228 0.0209
607 CHOLECYSTECTOMY 239 0.0209
608 COUGH 5861 0.0209
609 RECTAL HAEMORRHAGE 897 0.0209
610 ACUTE RESPIRATORY DISTRESS SYNDROME 369 0.0208
611 HEART RATE INCREASED 2062 0.0208
612 SMALL INTESTINAL OBSTRUCTION 256 0.0208
613 SPINAL OPERATION 256 0.0208
614 EOSINOPHILIA 363 0.0207
615 OXYGEN SATURATION DECREASED 1164 0.0207
616 RASH GENERALISED 536 0.0207
617 DIARRHOEA 13358 0.0207
618 ADRENAL INSUFFICIENCY 251 0.0207
619 GASTRIC ULCER 392 0.0206
620 DIPLOPIA 535 0.0206
621 INJECTION SITE IRRITATION 262 0.0206
622 MYOCLONUS 245 0.0205
623 PERIPHERAL COLDNESS 281 0.0204
624 HOSPICE CARE 202 0.0204
625 THINKING ABNORMAL 381 0.0204
626 VENTRICULAR EXTRASYSTOLES 212 0.0204
627 FOETAL EXPOSURE DURING PREGNANCY 1658 0.0204
628 ARTHROPATHY 1125 0.0202
629 HYPOAESTHESIA ORAL 305 0.0202
630 EYE DISCHARGE 210 0.0202
631 VIRAL INFECTION 672 0.0202
632 BLOOD CREATINE PHOSPHOKINASE INCREASED 580 0.0201
633 EXTRA DOSE ADMINISTERED 816 0.0201
634 TRANSFUSION 211 0.0201
635 PALPITATIONS 2358 0.0201
636 KNEE ARTHROPLASTY 423 0.0201
637 APHONIA 280 0.0200
638 CIRCULATORY COLLAPSE 341 0.0200
639 BLISTER 1120 0.0199
640 HAEMORRHOIDS 389 0.0199
641 PHARYNGEAL SWELLING 195 0.0199
642 DECREASED ACTIVITY 215 0.0199
643 SOMNOLENCE 4008 0.0199
644 MUSCULOSKELETAL PAIN 1042 0.0199
645 HEART RATE DECREASED 697 0.0198
646 DIVERTICULITIS 550 0.0198
647 WHITE BLOOD CELL COUNT INCREASED 760 0.0198
648 SKIN INFECTION 222 0.0198
649 MICTURITION URGENCY 226 0.0198
650 PRODUCT USE COMPLAINT 311 0.0197
651 DRY MOUTH 1596 0.0197
652 RHINORRHOEA 1270 0.0196
653 DEVICE RELATED INFECTION 302 0.0196
654 HYPOAESTHESIA 2931 0.0196
655 SINUS TACHYCARDIA 278 0.0196
656 PRODUCT DOSE OMISSION ISSUE 5755 0.0196
657 CHEST DISCOMFORT 1998 0.0195
658 SURGERY 1141 0.0194
659 EJECTION FRACTION DECREASED 302 0.0194
660 HYPERTHYROIDISM 281 0.0194
661 GAMMA-GLUTAMYLTRANSFERASE INCREASED 430 0.0194
662 BACK PAIN 4506 0.0194
663 URINARY RETENTION 646 0.0193
664 PRODUCT ADMINISTRATION ERROR 389 0.0192
665 ASPARTATE AMINOTRANSFERASE INCREASED 1022 0.0192
666 FAECES DISCOLOURED 417 0.0192
667 TOOTH FRACTURE 212 0.0192
668 MUSCULOSKELETAL DISORDER 362 0.0190
669 DYSPHONIA 1112 0.0190
670 BURNING SENSATION 1333 0.0190
671 BLOOD BILIRUBIN INCREASED 510 0.0189
672 BONE DISORDER 344 0.0189
673 INTENTIONAL PRODUCT USE ISSUE 1653 0.0189
674 NASOPHARYNGITIS 3476 0.0188
675 RED BLOOD CELL COUNT DECREASED 538 0.0188
676 HEPATITIS C 227 0.0188
677 FEELING HOT 1151 0.0188
678 PRODUCT PRESCRIBING ISSUE 409 0.0188
679 BIPOLAR DISORDER 204 0.0187
680 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1334 0.0187
681 BLOOD PRESSURE FLUCTUATION 450 0.0187
682 FEMUR FRACTURE 580 0.0187
683 SLEEP DISORDER 1320 0.0187
684 MUSCULOSKELETAL CHEST PAIN 289 0.0187
685 NEOPLASM 214 0.0186
686 WRONG TECHNIQUE IN DRUG USAGE PROCESS 676 0.0186
687 RESPIRATORY DISORDER 556 0.0186
688 INFECTION 2686 0.0185
689 CONDITION AGGRAVATED 5642 0.0185
690 ABDOMINAL DISCOMFORT 3107 0.0185
691 RESTLESS LEGS SYNDROME 336 0.0185
692 CYST 229 0.0184
693 ALANINE AMINOTRANSFERASE INCREASED 1130 0.0184
694 ANXIETY 5235 0.0184
695 CONVULSION 1050 0.0183
696 VERTIGO 1116 0.0183
697 DRUG LEVEL INCREASED 303 0.0183
698 CHROMATURIA 413 0.0183
699 HERNIA 353 0.0182
700 HEPATOCELLULAR INJURY 257 0.0181
701 SKIN DISCOLOURATION 833 0.0181
702 OESOPHAGITIS 198 0.0181
703 MOVEMENT DISORDER 581 0.0181
704 BLOOD TEST ABNORMAL 254 0.0181
705 MUSCLE SPASMS 3311 0.0180
706 SPINAL PAIN 211 0.0180
707 SWOLLEN TONGUE 562 0.0180
708 METASTASES TO LIVER 316 0.0180
709 DEPRESSION 4085 0.0179
710 ASTHMA 2029 0.0179
711 GASTROINTESTINAL DISORDER 1598 0.0178
712 HEPATIC CYTOLYSIS 227 0.0178
713 SINUSITIS 1824 0.0178
714 RESPIRATORY TRACT INFECTION 463 0.0178
715 INTESTINAL OBSTRUCTION 668 0.0177
716 RASH MACULO-PAPULAR 394 0.0177
717 TACHYCARDIA 1570 0.0177
718 LOCAL SWELLING 308 0.0176
719 PANCYTOPENIA 985 0.0176
720 GASTRIC HAEMORRHAGE 202 0.0175
721 SKIN LESION 481 0.0175
722 PULMONARY THROMBOSIS 191 0.0175
723 BLADDER CANCER 1030 0.0175
724 LYMPHOMA 269 0.0174
725 LACRIMATION INCREASED 523 0.0173
726 MUSCLE TWITCHING 399 0.0173
727 DYSPHAGIA 1642 0.0173
728 EPISTAXIS 1294 0.0173
729 DELIRIUM 600 0.0173
730 PERITONITIS 358 0.0173
731 OCULAR DISCOMFORT 194 0.0173
732 SECRETION DISCHARGE 216 0.0172
733 TOOTH INFECTION 227 0.0172
734 INTRAOCULAR PRESSURE INCREASED 220 0.0172
735 FATIGUE 13362 0.0171
736 BLOOD URINE PRESENT 324 0.0170
737 PARAESTHESIA ORAL 246 0.0170
738 INTENTIONAL DOSE OMISSION 485 0.0170
739 PULMONARY EMBOLISM 1614 0.0170
740 DEPRESSED MOOD 895 0.0169
741 AGRANULOCYTOSIS 314 0.0169
742 EYE PAIN 953 0.0169
743 HEAD DISCOMFORT 299 0.0169
744 INJECTION SITE URTICARIA 414 0.0169
745 GASTRIC DISORDER 579 0.0169
746 HERPES ZOSTER 969 0.0168
747 RASH PRURITIC 910 0.0168
748 THROMBOCYTOPENIA 1874 0.0167
749 DEVICE DELIVERY SYSTEM ISSUE 458 0.0167
750 POOR QUALITY SLEEP 360 0.0167
751 IMMUNE SYSTEM DISORDER 220 0.0167
752 TASTE DISORDER 338 0.0166
753 DRUG EFFECT DECREASED 897 0.0166
754 THERAPEUTIC RESPONSE DECREASED 1009 0.0166
755 DYSGEUSIA 1236 0.0166
756 HAIR TEXTURE ABNORMAL 222 0.0166
757 LOWER RESPIRATORY TRACT INFECTION 754 0.0166
758 BRAIN OEDEMA 209 0.0165
759 OSTEOPOROSIS 680 0.0165
760 TENDON RUPTURE 204 0.0165
761 PAIN 10149 0.0165
762 MYALGIA 2802 0.0165
763 JOINT RANGE OF MOTION DECREASED 221 0.0165
764 DRUG INEFFECTIVE 21711 0.0165
765 NECK PAIN 920 0.0164
766 HEADACHE 10283 0.0164
767 ERECTILE DYSFUNCTION 421 0.0164
768 EYE SWELLING 609 0.0164
769 BURSITIS 198 0.0163
770 THYROID CANCER 196 0.0163
771 CHILLS 1909 0.0163
772 PLATELET COUNT DECREASED 1735 0.0163
773 PYREXIA 5616 0.0162
774 LIVER FUNCTION TEST ABNORMAL 471 0.0162
775 CLOSTRIDIUM DIFFICILE INFECTION 352 0.0161
776 HEPATITIS 412 0.0161
777 COVID-19 2824 0.0161
778 DISTURBANCE IN ATTENTION 868 0.0161
779 MENTAL DISORDER 698 0.0160
780 RESPIRATORY ARREST 440 0.0159
781 POLYNEUROPATHY 191 0.0159
782 PNEUMOTHORAX 252 0.0159
783 NASAL CONGESTION 931 0.0158
784 EAR INFECTION 421 0.0158
785 SKIN DISORDER 527 0.0158
786 RESTLESSNESS 578 0.0158
787 DEEP VEIN THROMBOSIS 1024 0.0157
788 MUSCLE TIGHTNESS 255 0.0157
789 TRANSAMINASES INCREASED 350 0.0157
790 EAR PAIN 306 0.0157
791 LYMPHOCYTE COUNT DECREASED 278 0.0157
792 INJECTION SITE RASH 482 0.0157
793 PHARYNGEAL OEDEMA 241 0.0157
794 HAEMATOCHEZIA 858 0.0155
795 INSOMNIA 4136 0.0155
796 NIGHT SWEATS 499 0.0155
797 COGNITIVE DISORDER 720 0.0154
798 CANDIDA INFECTION 260 0.0154
799 CONTRAINDICATED PRODUCT ADMINISTERED 463 0.0153
800 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 734 0.0153
801 HIP ARTHROPLASTY 234 0.0153
802 BLOOD LACTATE DEHYDROGENASE INCREASED 242 0.0153
803 HALLUCINATION 1151 0.0153
804 DEVICE BREAKAGE 618 0.0152
805 INJECTION SITE PRURITUS 1019 0.0152
806 DISSEMINATED INTRAVASCULAR COAGULATION 214 0.0152
807 LIP SWELLING 503 0.0151
808 NERVOUS SYSTEM DISORDER 469 0.0150
809 SUICIDE ATTEMPT 910 0.0150
810 C-REACTIVE PROTEIN INCREASED 545 0.0150
811 SWELLING FACE 974 0.0149
812 AGITATION 1096 0.0149
813 PRURITUS 5715 0.0149
814 ORAL PAIN 332 0.0148
815 COLITIS 561 0.0148
816 HYPERSENSITIVITY 2745 0.0148
817 BLOOD COUNT ABNORMAL 223 0.0147
818 LIVER FUNCTION TEST INCREASED 315 0.0147
819 BODY TEMPERATURE INCREASED 299 0.0146
820 SEIZURE 1690 0.0146
821 ACTIVITIES OF DAILY LIVING IMPAIRED 289 0.0146
822 OSTEOPENIA 221 0.0145
823 CYANOSIS 229 0.0145
824 OROPHARYNGEAL PAIN 1340 0.0145
825 TENDONITIS 223 0.0144
826 SKIN REACTION 202 0.0143
827 INTENTIONAL OVERDOSE 918 0.0143
828 TOOTH DISORDER 318 0.0143
829 DRUG-INDUCED LIVER INJURY 448 0.0143
830 IMPAIRED WORK ABILITY 305 0.0143
831 FACE OEDEMA 240 0.0142
832 ARTHRALGIA 5905 0.0142
833 INTERSTITIAL LUNG DISEASE 685 0.0141
834 PULMONARY ARTERIAL HYPERTENSION 204 0.0141
835 JOINT SWELLING 1699 0.0141
836 ANGER 475 0.0140
837 HAEMORRHAGE INTRACRANIAL 210 0.0140
838 CHOKING 273 0.0140
839 ANAPHYLACTIC REACTION 768 0.0139
840 INFLAMMATION 717 0.0139
841 IMMUNODEFICIENCY 207 0.0139
842 PAIN IN JAW 390 0.0138
843 FULL BLOOD COUNT DECREASED 277 0.0137
844 HALLUCINATION, VISUAL 290 0.0137
845 FREQUENT BOWEL MOVEMENTS 371 0.0137
846 FRACTURE 258 0.0136
847 TINNITUS 625 0.0136
848 PARAESTHESIA 2133 0.0135
849 JOINT STIFFNESS 354 0.0135
850 CRYING 489 0.0134
851 ANGIOEDEMA 595 0.0134
852 THERAPEUTIC RESPONSE UNEXPECTED 600 0.0134
853 URTICARIA 2236 0.0133
854 LYMPHADENOPATHY 469 0.0132
855 SENSORY DISTURBANCE 212 0.0132
856 PHOTOPHOBIA 246 0.0131
857 STOMATITIS 792 0.0130
858 PNEUMONITIS 355 0.0130
859 MUSCULOSKELETAL STIFFNESS 1137 0.0130
860 LUNG NEOPLASM MALIGNANT 530 0.0129
861 THROAT TIGHTNESS 348 0.0129
862 HEPATIC FUNCTION ABNORMAL 480 0.0128
863 INFLUENZA LIKE ILLNESS 1057 0.0128
864 IRRITABILITY 767 0.0127
865 AGEUSIA 317 0.0127
866 PRODUCT DOSE OMISSION IN ERROR 359 0.0127
867 EYE PRURITUS 423 0.0126
868 RHEUMATOID ARTHRITIS 1427 0.0126
869 INSURANCE ISSUE 192 0.0125
870 HEPATIC ENZYME INCREASED 854 0.0125
871 FEBRILE NEUTROPENIA 826 0.0124
872 SEROTONIN SYNDROME 239 0.0124
873 SKIN EXFOLIATION 1049 0.0124
874 DYSKINESIA 502 0.0123
875 ABNORMAL BEHAVIOUR 489 0.0123
876 INJECTION SITE SWELLING 945 0.0123
877 ILL-DEFINED DISORDER 746 0.0123
878 DRUG ERUPTION 217 0.0122
879 RASH 5326 0.0122
880 SKIN CANCER 263 0.0122
881 MIDDLE INSOMNIA 228 0.0122
882 BONE PAIN 713 0.0122
883 ELECTROCARDIOGRAM QT PROLONGED 437 0.0121
884 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 406 0.0120
885 PANIC ATTACK 437 0.0120
886 DRUG INTOLERANCE 1155 0.0119
887 THROAT IRRITATION 532 0.0118
888 METASTASES TO BONE 194 0.0118
889 RASH PAPULAR 264 0.0118
890 FLUSHING 1195 0.0117
891 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 274 0.0117
892 PROCEDURAL PAIN 325 0.0117
893 PLASMA CELL MYELOMA 457 0.0117
894 MOOD ALTERED 316 0.0116
895 ABORTION SPONTANEOUS 462 0.0115
896 IRRITABLE BOWEL SYNDROME 247 0.0115
897 STEVENS-JOHNSON SYNDROME 255 0.0115
898 LABORATORY TEST ABNORMAL 337 0.0114
899 EMOTIONAL DISORDER 352 0.0114
900 RASH MACULAR 399 0.0114
901 DRY EYE 569 0.0114
902 CYTOMEGALOVIRUS INFECTION 189 0.0114
903 ERYTHEMA 2328 0.0113
904 RASH ERYTHEMATOUS 540 0.0113
905 INJECTION SITE ERYTHEMA 1394 0.0112
906 MOUTH ULCERATION 234 0.0111
907 HEPATOTOXICITY 247 0.0111
908 PRESCRIBED OVERDOSE 214 0.0110
909 EPILEPSY 335 0.0109
910 HOT FLUSH 825 0.0109
911 PSORIASIS 1428 0.0109
912 LEUKOPENIA 545 0.0109
913 INJECTION SITE REACTION 748 0.0109
914 ABDOMINAL PAIN LOWER 274 0.0108
915 DEATH 9206 0.0107
916 PRESCRIBED UNDERDOSE 212 0.0106
917 EMOTIONAL DISTRESS 1279 0.0106
918 MIGRAINE 1004 0.0105
919 PRODUCT PREPARATION ERROR 216 0.0105
920 ABNORMAL DREAMS 290 0.0105
921 DERMATITIS 219 0.0104
922 WHITE BLOOD CELL COUNT DECREASED 1123 0.0103
923 ALOPECIA 2027 0.0103
924 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 265 0.0103
925 THERAPY CESSATION 527 0.0103
926 LIVER INJURY 251 0.0102
927 AGGRESSION 511 0.0102
928 MUCOSAL INFLAMMATION 264 0.0101
929 TOOTH LOSS 208 0.0100
930 OCULAR HYPERAEMIA 472 0.0099
931 BONE MARROW FAILURE 202 0.0099
932 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 694 0.0097
933 PSORIATIC ARTHROPATHY 393 0.0097
934 PRODUCT PHYSICAL ISSUE 195 0.0097
935 TOXICITY TO VARIOUS AGENTS 1628 0.0096
936 SUICIDAL IDEATION 880 0.0096
937 COMPLETED SUICIDE 801 0.0096
938 CYTOKINE RELEASE SYNDROME 192 0.0096
939 BREAST CANCER 890 0.0095
940 NEUTROPHIL COUNT DECREASED 386 0.0095
941 PAIN OF SKIN 255 0.0095
942 EYE IRRITATION 544 0.0094
943 OVERDOSE 2030 0.0094
944 NEUTROPENIA 1270 0.0093
945 ADVERSE EVENT 860 0.0093
946 HEPATIC CANCER 223 0.0093
947 THERAPY NON-RESPONDER 416 0.0092
948 INTENTIONAL DRUG MISUSE 193 0.0092
949 OSTEONECROSIS OF JAW 228 0.0092
950 ANAPHYLACTIC SHOCK 235 0.0091
951 GLOSSODYNIA 202 0.0090
952 MOOD SWINGS 283 0.0089
953 PSYCHOTIC DISORDER 262 0.0089
954 DRUG EFFECT INCOMPLETE 320 0.0088
955 DISEASE PROGRESSION 1024 0.0086
956 NIGHTMARE 297 0.0086
957 SEDATION 224 0.0085
958 ECZEMA 435 0.0083
959 MALIGNANT NEOPLASM PROGRESSION 848 0.0083
960 DRUG DOSE OMISSION BY DEVICE 648 0.0083
961 INFUSION RELATED REACTION 546 0.0082
962 VAGINAL HAEMORRHAGE 354 0.0081
963 DRUG RESISTANCE 209 0.0081
964 PRODUCT USE IN UNAPPROVED INDICATION 2004 0.0081
965 DRY SKIN 1079 0.0081
966 THERAPEUTIC PRODUCT EFFECT DECREASED 358 0.0080
967 THERAPY INTERRUPTED 570 0.0080
968 ADVERSE DRUG REACTION 715 0.0080
969 NO ADVERSE EVENT 1441 0.0079
970 PRODUCT SUBSTITUTION ISSUE 437 0.0076
971 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 413 0.0075
972 SYSTEMIC LUPUS ERYTHEMATOSUS 266 0.0075
973 NEOPLASM PROGRESSION 250 0.0072
974 INCORRECT ROUTE OF DRUG ADMINISTRATION 256 0.0072
975 COLITIS ULCERATIVE 318 0.0071
976 MULTIPLE SCLEROSIS 335 0.0070
977 DISEASE RECURRENCE 332 0.0070
978 TARDIVE DYSKINESIA 194 0.0069
979 SKIN IRRITATION 291 0.0063
980 OSTEONECROSIS 208 0.0063
981 THERAPEUTIC RESPONSE SHORTENED 206 0.0062
982 WITHDRAWAL SYNDROME 248 0.0059
983 SKIN BURNING SENSATION 415 0.0058
984 PROSTATE CANCER 459 0.0057
985 RENAL CANCER 265 0.0056
986 ACNE 387 0.0051
987 MULTIPLE SCLEROSIS RELAPSE 327 0.0048
988 DRUG ABUSE 382 0.0046
989 TREATMENT FAILURE 356 0.0043
990 DEVICE DIFFICULT TO USE 265 0.0040
991 DRUG WITHDRAWAL SYNDROME 328 0.0037
992 DRUG DEPENDENCE 278 0.0017